Publications

Search ACTG publications from 1/1/2006 to current.

Search

Filter results by

Found 688 results
Found 688 results.
Skip Alphabet Links A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

Z

Zolopa A, Andersen J, Powderly W, et al. "Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial." PLoS ONE. 2009;4(5):e5575.
Zhou L, Kitch DW, Evans SR, et al. "Correlates of epidermal nerve fiber densities in HIV-associated distal sensory polyneuropathy." Neurology. 2007;68(24):2113-9.
Zheng L, Taiwo B, Gandhi RT, et al. "Factors associated with CD8+ T-cell activation in HIV-1-infected patients on long-term antiretroviral therapy." J. Acquir. Immune Defic. Syndr.. 2014;67(2):153-60.
Zheng L, Rosenkranz SL, Taiwo B, Para MF, Eron JJ, Hughes MD. "The design of single-arm clinical trials of combination antiretroviral regimens for treatment-naive HIV-infected patients." AIDS Res. Hum. Retroviruses. 2013;29(4):652-7.
Zheng L, Bosch RJ, Chan ES, et al. "Predictors of residual viraemia in patients on long-term suppressive antiretroviral therapy." Antivir. Ther. (Lond.). 2013;18(1):39-43.
Zheng Y, Hughes MD, Lockman S, et al. "Antiretroviral therapy and efficacy after virologic failure on first-line boosted protease inhibitor regimens." Clin. Infect. Dis.. 2014;59(6):888-96.
Zhao Y, Navia BA, Marra CM, et al. "Memantine for AIDS dementia complex: open-label report of ACTG 301." HIV Clin Trials. 2010;11(1):59-67.
Zhang X, Hunt PW, Hammer SM, Cespedes MS, Patterson KB, Bosch RJ. "Immune Activation While on Potent Antiretroviral Therapy Can Predict Subsequent CD4+ T-Cell Increases Through 15 Years of Treatment." HIV Clin Trials. 2013;14(2):61-7.
Zhang X, Tierney C, Albrecht M, et al. "Discordant associations between SLCO1B1 521T→C and plasma levels of ritonavir-boosted protease inhibitors in AIDS clinical trials group study A5146." Ther Drug Monit. 2013;35(2):209-16.

Y

Yuste E, Sanford HB, Carmody J, et al. "Simian immunodeficiency virus engrafted with human immunodeficiency virus type 1 (HIV-1)-specific epitopes: replication, neutralization, and survey of HIV-1-positive plasma." J. Virol.. 2006;80(6):3030-41.
Younes S-A, Freeman ML, Mudd JC, et al. "IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infection." J. Clin. Invest.. 2016;126(7):2745-56.
Yonkers NL, Rodriguez B, Milkovich KA, et al. "TLR ligand-dependent activation of naive CD4 T cells by plasmacytoid dendritic cells is impaired in hepatitis C virus infection." J. Immunol.. 2007;178(7):4436-44.
Yonkers NL, Rodriguez B, Post AB, et al. "HIV coinfection impairs CD28-mediated costimulation of hepatitis C virus-specific CD8 cells." J. Infect. Dis.. 2006;194(3):391-400.
Yin MT, Chan ES, Brown TT, et al. "Racial differences in calculated bioavailable vitamin D with vitamin D/calcium supplementation." AIDS. 2017;31(17):2337-2344.
Yin MT, Kendall MA, Wu X, et al. "Fractures after antiretroviral initiation." AIDS. 2012;26(17):2175-84.
Yiannoutsos CT, Nakas CT, Navia BA. "Assessing multiple-group diagnostic problems with multi-dimensional receiver operating characteristic surfaces: application to proton MR Spectroscopy (MRS) in HIV-related neurological injury." Neuroimage. 2008;40(1):248-55.
Yeh T-min, Evans SR, Gulick RM, Clifford DB. "Vicriviroc and peripheral neuropathy: results from AIDS Clinical Trials Group 5211." HIV Clin Trials. 2010;11(1):51-8.
Yang Y, Degruttola V. "Resampling-based methods in single and multiple testing for equality of covariance/correlation matrices." Int J Biostat. 2012;8(1):Article 13.
Yamamoto T, Price DA, Casazza JP, et al. "Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection." Blood. 2011;117(18):4805-15.

W

Wyatt CM, Kitch D, Gupta SK, et al. "Changes in proteinuria and albuminuria with initiation of antiretroviral therapy: data from a randomized trial comparing tenofovir disoproxil fumarate/emtricitabine versus abacavir/lamivudine." J. Acquir. Immune Defic. Syndr.. 2014;67(1):36-44.
Wu H, Huang Y, Acosta EP, et al. "Pharmacodynamics of antiretroviral agents in HIV-1 infected patients: using viral dynamic models that incorporate drug susceptibility and adherence." J Pharmacokinet Pharmacodyn. 2006;33(4):399-419.
Wood BR, Komarow L, Zolopa AR, Finkelman MA, Powderly WG, Sax PE. "Test performance of blood beta-glucan for Pneumocystis jirovecii pneumonia in patients with AIDS and respiratory symptoms." AIDS. 2013;27(6):967-72.
Wohl DA, Kendall MA, Andersen J, et al. "Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030." HIV Clin Trials. 2009;10(3):143-52.
Wohl DA, Kendall MA, Feinberg J, et al. "The clinical impact of continuing to prescribe antiretroviral therapy in patients with advanced AIDS who manifest no virologic or immunologic benefit." PLoS ONE. 2013;8(11):e78676.
Williams P, Wu J, Cohn S, et al. "Improvement in lipid profiles over 6 years of follow-up in adults with AIDS and immune reconstitution." HIV Med.. 2009;10(5):290-301.
Wilkin TJ, Su Z, Krambrink A, et al. "Three-year safety and efficacy of vicriviroc, a CCR5 antagonist, in HIV-1-infected treatment-experienced patients." J. Acquir. Immune Defic. Syndr.. 2010;54(5):470-6.
Wilkin TJ, McKinnon JE, A DiRienzo G, et al. "Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy: final 48-week clinical and virologic outcomes." J. Infect. Dis.. 2009;199(6):866-71.
Wilkin TJ, Lalama CM, McKinnon J, et al. "A pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4⁺ T-cell recovery despite sustained virologic suppression: ACTG A5256." J. Infect. Dis.. 2012;206(4):534-42.
Wilkin TJ, Ribaudo HR, Tenorio AR, Gulick RM. "The relationship of CCR5 antagonists to CD4+ T-cell gain: a meta-regression of recent clinical trials in treatment-experienced HIV-infected patients." HIV Clin Trials. 2010;11(6):351-8.
Wilkin T, Lee JY, Lensing SY, et al. "High-grade anal intraepithelial neoplasia among HIV-1-infected men screening for a multicenter clinical trial of a human papillomavirus vaccine." HIV Clin Trials. 2013;14(2):75-9.

Pages